Autoantibodies against type I IFNs in patients with critical influenza pneumonia
© 2022 Zhang et al..
Autoantibodies neutralizing type I interferons (IFNs) can underlie critical COVID-19 pneumonia and yellow fever vaccine disease. We report here on 13 patients harboring autoantibodies neutralizing IFN-α2 alone (five patients) or with IFN-ω (eight patients) from a cohort of 279 patients (4.7%) aged 6-73 yr with critical influenza pneumonia. Nine and four patients had antibodies neutralizing high and low concentrations, respectively, of IFN-α2, and six and two patients had antibodies neutralizing high and low concentrations, respectively, of IFN-ω. The patients' autoantibodies increased influenza A virus replication in both A549 cells and reconstituted human airway epithelia. The prevalence of these antibodies was significantly higher than that in the general population for patients <70 yr of age (5.7 vs. 1.1%, P = 2.2 × 10-5), but not >70 yr of age (3.1 vs. 4.4%, P = 0.68). The risk of critical influenza was highest in patients with antibodies neutralizing high concentrations of both IFN-α2 and IFN-ω (OR = 11.7, P = 1.3 × 10-5), especially those <70 yr old (OR = 139.9, P = 3.1 × 10-10). We also identified 10 patients in additional influenza patient cohorts. Autoantibodies neutralizing type I IFNs account for ∼5% of cases of life-threatening influenza pneumonia in patients <70 yr old.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:219 |
|---|---|
| Enthalten in: |
The Journal of experimental medicine - 219(2022), 11 vom: 07. Nov. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhang, Qian [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Autoantibodies |
|---|
| Anmerkungen: |
Date Completed 20.09.2022 Date Revised 16.05.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1084/jem.20220514 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM346291127 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM346291127 | ||
| 003 | DE-627 | ||
| 005 | 20231226031055.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1084/jem.20220514 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1154.xml |
| 035 | |a (DE-627)NLM346291127 | ||
| 035 | |a (NLM)36112363 | ||
| 035 | |a (PII)e20220514 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zhang, Qian |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Autoantibodies against type I IFNs in patients with critical influenza pneumonia |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.09.2022 | ||
| 500 | |a Date Revised 16.05.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 Zhang et al. | ||
| 520 | |a Autoantibodies neutralizing type I interferons (IFNs) can underlie critical COVID-19 pneumonia and yellow fever vaccine disease. We report here on 13 patients harboring autoantibodies neutralizing IFN-α2 alone (five patients) or with IFN-ω (eight patients) from a cohort of 279 patients (4.7%) aged 6-73 yr with critical influenza pneumonia. Nine and four patients had antibodies neutralizing high and low concentrations, respectively, of IFN-α2, and six and two patients had antibodies neutralizing high and low concentrations, respectively, of IFN-ω. The patients' autoantibodies increased influenza A virus replication in both A549 cells and reconstituted human airway epithelia. The prevalence of these antibodies was significantly higher than that in the general population for patients <70 yr of age (5.7 vs. 1.1%, P = 2.2 × 10-5), but not >70 yr of age (3.1 vs. 4.4%, P = 0.68). The risk of critical influenza was highest in patients with antibodies neutralizing high concentrations of both IFN-α2 and IFN-ω (OR = 11.7, P = 1.3 × 10-5), especially those <70 yr old (OR = 139.9, P = 3.1 × 10-10). We also identified 10 patients in additional influenza patient cohorts. Autoantibodies neutralizing type I IFNs account for ∼5% of cases of life-threatening influenza pneumonia in patients <70 yr old | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 7 | |a Autoantibodies |2 NLM | |
| 650 | 7 | |a Interferon Type I |2 NLM | |
| 650 | 7 | |a Yellow Fever Vaccine |2 NLM | |
| 700 | 1 | |a Pizzorno, Andrés |e verfasserin |4 aut | |
| 700 | 1 | |a Miorin, Lisa |e verfasserin |4 aut | |
| 700 | 1 | |a Bastard, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Gervais, Adrian |e verfasserin |4 aut | |
| 700 | 1 | |a Le Voyer, Tom |e verfasserin |4 aut | |
| 700 | 1 | |a Bizien, Lucy |e verfasserin |4 aut | |
| 700 | 1 | |a Manry, Jeremy |e verfasserin |4 aut | |
| 700 | 1 | |a Rosain, Jérémie |e verfasserin |4 aut | |
| 700 | 1 | |a Philippot, Quentin |e verfasserin |4 aut | |
| 700 | 1 | |a Goavec, Kelian |e verfasserin |4 aut | |
| 700 | 1 | |a Padey, Blandine |e verfasserin |4 aut | |
| 700 | 1 | |a Cupic, Anastasija |e verfasserin |4 aut | |
| 700 | 1 | |a Laurent, Emilie |e verfasserin |4 aut | |
| 700 | 1 | |a Saker, Kahina |e verfasserin |4 aut | |
| 700 | 1 | |a Vanker, Martti |e verfasserin |4 aut | |
| 700 | 1 | |a Särekannu, Karita |e verfasserin |4 aut | |
| 700 | 0 | |a COVID Human Genetic Effort |e verfasserin |4 aut | |
| 700 | 0 | |a Etablissement Français du Sang Study Group |e verfasserin |4 aut | |
| 700 | 0 | |a Constances Cohort |e verfasserin |4 aut | |
| 700 | 0 | |a 3C-Dijon Study |e verfasserin |4 aut | |
| 700 | 0 | |a Cerba HealthCare Group |e verfasserin |4 aut | |
| 700 | 0 | |a Lyon Antigrippe Working Group |e verfasserin |4 aut | |
| 700 | 0 | |a REIPI INF Working Group |e verfasserin |4 aut | |
| 700 | 1 | |a García-Salum, Tamara |e verfasserin |4 aut | |
| 700 | 1 | |a Ferres, Marcela |e verfasserin |4 aut | |
| 700 | 1 | |a Le Corre, Nicole |e verfasserin |4 aut | |
| 700 | 1 | |a Sánchez-Céspedes, Javier |e verfasserin |4 aut | |
| 700 | 1 | |a Balsera-Manzanero, María |e verfasserin |4 aut | |
| 700 | 1 | |a Carratala, Jordi |e verfasserin |4 aut | |
| 700 | 1 | |a Retamar-Gentil, Pilar |e verfasserin |4 aut | |
| 700 | 1 | |a Abelenda-Alonso, Gabriela |e verfasserin |4 aut | |
| 700 | 1 | |a Valiente, Adoración |e verfasserin |4 aut | |
| 700 | 1 | |a Tiberghien, Pierre |e verfasserin |4 aut | |
| 700 | 1 | |a Zins, Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Debette, Stéphanie |e verfasserin |4 aut | |
| 700 | 1 | |a Meyts, Isabelle |e verfasserin |4 aut | |
| 700 | 1 | |a Haerynck, Filomeen |e verfasserin |4 aut | |
| 700 | 1 | |a Castagnoli, Riccardo |e verfasserin |4 aut | |
| 700 | 1 | |a Notarangelo, Luigi D |e verfasserin |4 aut | |
| 700 | 1 | |a Gonzalez-Granado, Luis I |e verfasserin |4 aut | |
| 700 | 1 | |a Dominguez-Pinilla, Nerea |e verfasserin |4 aut | |
| 700 | 1 | |a Andreakos, Evangelos |e verfasserin |4 aut | |
| 700 | 1 | |a Triantafyllia, Vasiliki |e verfasserin |4 aut | |
| 700 | 1 | |a Rodríguez-Gallego, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Solé-Violán, Jordi |e verfasserin |4 aut | |
| 700 | 1 | |a Ruiz-Hernandez, José Juan |e verfasserin |4 aut | |
| 700 | 1 | |a Rodríguez de Castro, Felipe |e verfasserin |4 aut | |
| 700 | 1 | |a Ferreres, José |e verfasserin |4 aut | |
| 700 | 1 | |a Briones, Marisa |e verfasserin |4 aut | |
| 700 | 1 | |a Wauters, Joost |e verfasserin |4 aut | |
| 700 | 1 | |a Vanderbeke, Lore |e verfasserin |4 aut | |
| 700 | 1 | |a Feys, Simon |e verfasserin |4 aut | |
| 700 | 1 | |a Kuo, Chen-Yen |e verfasserin |4 aut | |
| 700 | 1 | |a Lei, Wei-Te |e verfasserin |4 aut | |
| 700 | 1 | |a Ku, Cheng-Lung |e verfasserin |4 aut | |
| 700 | 1 | |a Tal, Galit |e verfasserin |4 aut | |
| 700 | 1 | |a Etzioni, Amos |e verfasserin |4 aut | |
| 700 | 1 | |a Hanna, Suhair |e verfasserin |4 aut | |
| 700 | 1 | |a Fournet, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Casalegno, Jean-Sebastien |e verfasserin |4 aut | |
| 700 | 1 | |a Queromes, Gregory |e verfasserin |4 aut | |
| 700 | 1 | |a Argaud, Laurent |e verfasserin |4 aut | |
| 700 | 1 | |a Javouhey, Etienne |e verfasserin |4 aut | |
| 700 | 1 | |a Rosa-Calatrava, Manuel |e verfasserin |4 aut | |
| 700 | 1 | |a Cordero, Elisa |e verfasserin |4 aut | |
| 700 | 1 | |a Aydillo, Teresa |e verfasserin |4 aut | |
| 700 | 1 | |a Medina, Rafael A |e verfasserin |4 aut | |
| 700 | 1 | |a Kisand, Kai |e verfasserin |4 aut | |
| 700 | 1 | |a Puel, Anne |e verfasserin |4 aut | |
| 700 | 1 | |a Jouanguy, Emmanuelle |e verfasserin |4 aut | |
| 700 | 1 | |a Abel, Laurent |e verfasserin |4 aut | |
| 700 | 1 | |a Cobat, Aurélie |e verfasserin |4 aut | |
| 700 | 1 | |a Trouillet-Assant, Sophie |e verfasserin |4 aut | |
| 700 | 1 | |a García-Sastre, Adolfo |e verfasserin |4 aut | |
| 700 | 1 | |a Casanova, Jean-Laurent |e verfasserin |4 aut | |
| 700 | 1 | |a Abel, Laurent |e investigator |4 oth | |
| 700 | 1 | |a Aiuti, Alessandro |e investigator |4 oth | |
| 700 | 1 | |a Al-Muhsen, Saleh |e investigator |4 oth | |
| 700 | 1 | |a Al-Mulla, Fahd |e investigator |4 oth | |
| 700 | 1 | |a Anderson, Mark S |e investigator |4 oth | |
| 700 | 1 | |a Andreakos, Evangelos |e investigator |4 oth | |
| 700 | 1 | |a Arias, Andrés A |e investigator |4 oth | |
| 700 | 1 | |a Baris Feldman, Hagit |e investigator |4 oth | |
| 700 | 1 | |a Belot, Alexandre |e investigator |4 oth | |
| 700 | 1 | |a Biggs, Catherine M |e investigator |4 oth | |
| 700 | 1 | |a Bogunovic, Dusan |e investigator |4 oth | |
| 700 | 1 | |a Bolze, Alexandre |e investigator |4 oth | |
| 700 | 1 | |a Bondarenko, Anastasiia |e investigator |4 oth | |
| 700 | 1 | |a Bousfiha, Ahmed A |e investigator |4 oth | |
| 700 | 1 | |a Brodin, Petter |e investigator |4 oth | |
| 700 | 1 | |a Bryceson, Yenan |e investigator |4 oth | |
| 700 | 1 | |a Bustamante, Carlos D |e investigator |4 oth | |
| 700 | 1 | |a Butte, Manish J |e investigator |4 oth | |
| 700 | 1 | |a Casari, Giorgio |e investigator |4 oth | |
| 700 | 1 | |a Christodoulou, John |e investigator |4 oth | |
| 700 | 1 | |a Condino-Neto, Antonio |e investigator |4 oth | |
| 700 | 1 | |a Constantinescu, Stefan N |e investigator |4 oth | |
| 700 | 1 | |a Cooper, Megan A |e investigator |4 oth | |
| 700 | 1 | |a Dalgard, Clifton L |e investigator |4 oth | |
| 700 | 1 | |a Desai, Murkesh |e investigator |4 oth | |
| 700 | 1 | |a Drolet, Beth A |e investigator |4 oth | |
| 700 | 1 | |a El Baghdadi, Jamila |e investigator |4 oth | |
| 700 | 1 | |a Espinosa-Padilla, Sara |e investigator |4 oth | |
| 700 | 1 | |a Fellay, Jacques |e investigator |4 oth | |
| 700 | 1 | |a Flores, Carlos |e investigator |4 oth | |
| 700 | 1 | |a Fragkou, Paraskevi C |e investigator |4 oth | |
| 700 | 1 | |a Franco, José Luis |e investigator |4 oth | |
| 700 | 1 | |a Froidure, Antoine |e investigator |4 oth | |
| 700 | 1 | |a Galani, Ioanna Evdokia |e investigator |4 oth | |
| 700 | 1 | |a Gregersen, Peter K |e investigator |4 oth | |
| 700 | 1 | |a Grimbacher, Bodo |e investigator |4 oth | |
| 700 | 1 | |a Haerynck, Filomeen |e investigator |4 oth | |
| 700 | 1 | |a Hagin, David |e investigator |4 oth | |
| 700 | 1 | |a Halwani, Rabih |e investigator |4 oth | |
| 700 | 1 | |a Hammarström, Lennart |e investigator |4 oth | |
| 700 | 1 | |a Heath, James R |e investigator |4 oth | |
| 700 | 1 | |a Henrickson, Sarah E |e investigator |4 oth | |
| 700 | 1 | |a Hsieh, Elena W Y |e investigator |4 oth | |
| 700 | 1 | |a Husebye, Eystein |e investigator |4 oth | |
| 700 | 1 | |a Imai, Kohsuke |e investigator |4 oth | |
| 700 | 1 | |a Itan, Yuval |e investigator |4 oth | |
| 700 | 1 | |a Jarvis, Erich D |e investigator |4 oth | |
| 700 | 1 | |a Karamitros, Timokratis |e investigator |4 oth | |
| 700 | 1 | |a Kisand, Kai |e investigator |4 oth | |
| 700 | 1 | |a Koltsida, Ourania |e investigator |4 oth | |
| 700 | 1 | |a Ku, Cheng-Lung |e investigator |4 oth | |
| 700 | 1 | |a Lau, Yu-Lung |e investigator |4 oth | |
| 700 | 1 | |a Ling, Yun |e investigator |4 oth | |
| 700 | 1 | |a Lucas, Carrie L |e investigator |4 oth | |
| 700 | 1 | |a Maniatis, Tom |e investigator |4 oth | |
| 700 | 1 | |a Mansouri, Davood |e investigator |4 oth | |
| 700 | 1 | |a Maródi, László |e investigator |4 oth | |
| 700 | 1 | |a Meyts, Isabelle |e investigator |4 oth | |
| 700 | 1 | |a Milner, Joshua D |e investigator |4 oth | |
| 700 | 1 | |a Mironska, Kristina |e investigator |4 oth | |
| 700 | 1 | |a Mogensen, Trine H |e investigator |4 oth | |
| 700 | 1 | |a Morio, Tomohiro |e investigator |4 oth | |
| 700 | 1 | |a Ng, Lisa F P |e investigator |4 oth | |
| 700 | 1 | |a Notarangelo, Luigi D |e investigator |4 oth | |
| 700 | 1 | |a Novelli, Antonio |e investigator |4 oth | |
| 700 | 1 | |a Novelli, Giuseppe |e investigator |4 oth | |
| 700 | 1 | |a O'Farrelly, Cliona |e investigator |4 oth | |
| 700 | 1 | |a Okada, Satoshi |e investigator |4 oth | |
| 700 | 1 | |a Okamoto, Keisuke |e investigator |4 oth | |
| 700 | 1 | |a Ozcelik, Tayfun |e investigator |4 oth | |
| 700 | 1 | |a Pan-Hammarström, Qiang |e investigator |4 oth | |
| 700 | 1 | |a Pape, Jean W |e investigator |4 oth | |
| 700 | 1 | |a Perez de Diego, Rebeca |e investigator |4 oth | |
| 700 | 1 | |a Perlin, David S |e investigator |4 oth | |
| 700 | 1 | |a Pesole, Graziano |e investigator |4 oth | |
| 700 | 1 | |a Planas, Anna M |e investigator |4 oth | |
| 700 | 1 | |a Prando, Carolina |e investigator |4 oth | |
| 700 | 1 | |a Pujol, Aurora |e investigator |4 oth | |
| 700 | 1 | |a Quintana-Murci, Lluis |e investigator |4 oth | |
| 700 | 1 | |a Ramaswamy, Sathishkumar |e investigator |4 oth | |
| 700 | 1 | |a Rapti, Vasiliki |e investigator |4 oth | |
| 700 | 1 | |a Renia, Laurent |e investigator |4 oth | |
| 700 | 1 | |a Resnick, Igor |e investigator |4 oth | |
| 700 | 1 | |a Rodríguez-Gallego, Carlos |e investigator |4 oth | |
| 700 | 1 | |a Rovina, Nikoletta |e investigator |4 oth | |
| 700 | 1 | |a Sancho-Shimizu, Vanessa |e investigator |4 oth | |
| 700 | 1 | |a Sediva, Anna |e investigator |4 oth | |
| 700 | 1 | |a Seppänen, Mikko R J |e investigator |4 oth | |
| 700 | 1 | |a Shahrooei, Mohammed |e investigator |4 oth | |
| 700 | 1 | |a Shcherbina, Anna |e investigator |4 oth | |
| 700 | 1 | |a Slaby, Ondrej |e investigator |4 oth | |
| 700 | 1 | |a Snow, Andrew L |e investigator |4 oth | |
| 700 | 1 | |a Soler-Palacín, Pere |e investigator |4 oth | |
| 700 | 1 | |a Spaan, András N |e investigator |4 oth | |
| 700 | 1 | |a Tancevski, Ivan |e investigator |4 oth | |
| 700 | 1 | |a Tangye, Stuart G |e investigator |4 oth | |
| 700 | 1 | |a Abou Tayoun, Ahmad |e investigator |4 oth | |
| 700 | 1 | |a Temel, Şehime Gülsün |e investigator |4 oth | |
| 700 | 1 | |a Tsiodras, Sotirios |e investigator |4 oth | |
| 700 | 1 | |a Turvey, Stuart E |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of experimental medicine |d 1896 |g 219(2022), 11 vom: 07. Nov. |w (DE-627)NLM000005967 |x 1540-9538 |7 nnns |
| 773 | 1 | 8 | |g volume:219 |g year:2022 |g number:11 |g day:07 |g month:11 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1084/jem.20220514 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 219 |j 2022 |e 11 |b 07 |c 11 | ||